PMC:7200337 / 38682-38935
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T394 | 118-121 | Body_part | denotes | CSF | http://purl.org/sig/ont/fma/fma20935 |
T395 | 129-134 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T250 | 214-222 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T474 | 21-22 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T475 | 60-61 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T476 | 123-126 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T477 | 127-134 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T196 | 115-117 | Chemical | denotes | GM | http://purl.obolibrary.org/obo/CHEBI_74120 |
T197 | 165-167 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1288 | 115-121 | Gene | denotes | GM-CSF | Gene:1437 |
1289 | 123-126 | Gene | denotes | CD4 | Gene:920 |
1290 | 165-169 | Gene | denotes | IL-6 | Gene:3569 |
1291 | 174-179 | Gene | denotes | IFN-γ | Gene:3458 |
1298 | 223-231 | Species | denotes | patients | Tax:9606 |
1303 | 199-213 | Disease | denotes | critically ill | MESH:D016638 |
1304 | 214-222 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T211 | 0-253 | Sentence | denotes | This is suggested in a study by Zhou et al., which reported a significantly increased PBMC frequency of polyclonal GM-CSF+ CD4 T cells capable of prodigious ex vivo IL-6 and IFN-γ production only in critically ill COVID-19 patients (Zhou et al., 2020c). |